• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊癌诊断后的非癌症死因:基于人群的分析。

Non cancer causes of death after gallbladder cancer diagnosis: a population-based analysis.

机构信息

Department of Gastroenterology, The Affliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, China.

出版信息

Sci Rep. 2023 Aug 23;13(1):13746. doi: 10.1038/s41598-023-40134-4.

DOI:10.1038/s41598-023-40134-4
PMID:37612302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10447554/
Abstract

Mortality from non cancer causes in patients with gallbladder cancer (GBC) still unclear. This study evaluated the causes and risk factors of non cancer death during different follow-up periods after GBC diagnosis. Non cancer causes of death for GBC patients diagnosed between 2000 and 2017 in Surveillance, Epidemiology and End Results database were analyzed and standardized mortality rates (SMR) for each non cancer death were calculated. Predictors for non cancer death were identified through multivariate competing risk analysis. A total 11,927 GBC patients were identified for further analysis, 9393 died during follow up. The largest proportion of non cancer deaths occurred > 3 years after diagnosis (39.4%). Most common non cancer cause were cardiovascular disease (43.3%), followed by other cause of death (34.4%) and infectious diseases (8.6%). Compared with US general population, GBC patients has higher risk of death from disease of heart (SMR, 1.58; 95%CI, 1.41-1.75), septicemia (SMR,3.21; 95%CI, 2.27-4.40), diabetes mellitus (SMR,1.97; 95%CI, 1.43-2.63), alone with other causes. Non cancer causes accounted for a significant proportion of deaths during the follow-up period after GBC diagnosis. The risk of non cancer death is higher in GBC patients than in the general population. Our study provides comprehensive assessment of death from non cancer cause in GBC patients, which has important implications for health management in GBC patients.

摘要

胆囊癌(GBC)患者的非癌症死因仍不清楚。本研究评估了 GBC 诊断后不同随访期间非癌症死亡的原因和危险因素。分析了 2000 年至 2017 年间监测、流行病学和最终结果数据库中诊断为 GBC 的患者的非癌症死亡原因,并计算了每种非癌症死亡的标准化死亡率(SMR)。通过多变量竞争风险分析确定非癌症死亡的预测因素。共对 11927 名 GBC 患者进行了进一步分析,9393 名患者在随访期间死亡。非癌症死亡的最大比例发生在诊断后>3 年(39.4%)。最常见的非癌症死因是心血管疾病(43.3%),其次是其他死因(34.4%)和传染病(8.6%)。与美国一般人群相比,GBC 患者死于心脏病(SMR,1.58;95%CI,1.41-1.75)、败血症(SMR,3.21;95%CI,2.27-4.40)和糖尿病(SMR,1.97;95%CI,1.43-2.63)的风险更高,单独还有其他原因。非癌症原因在 GBC 诊断后随访期间占死亡的很大比例。GBC 患者的非癌症死亡风险高于一般人群。我们的研究提供了对 GBC 患者非癌症死亡原因的综合评估,这对 GBC 患者的健康管理具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0293/10447554/608fc407ac22/41598_2023_40134_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0293/10447554/608fc407ac22/41598_2023_40134_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0293/10447554/608fc407ac22/41598_2023_40134_Fig1_HTML.jpg

相似文献

1
Non cancer causes of death after gallbladder cancer diagnosis: a population-based analysis.胆囊癌诊断后的非癌症死因:基于人群的分析。
Sci Rep. 2023 Aug 23;13(1):13746. doi: 10.1038/s41598-023-40134-4.
2
Long-term causes of death among pediatric patients with cancer.儿童癌症患者的长期死因。
Cancer. 2020 Jul 1;126(13):3102-3113. doi: 10.1002/cncr.32885. Epub 2020 Apr 16.
3
Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study.结直肠癌诊断后的死亡原因:一项基于人群的研究。
Front Oncol. 2021 Mar 30;11:647179. doi: 10.3389/fonc.2021.647179. eCollection 2021.
4
Causes of death after breast cancer diagnosis: A US population-based analysis.乳腺癌诊断后的死因分析:一项基于美国人群的分析。
Cancer. 2020 Apr 1;126(7):1559-1567. doi: 10.1002/cncr.32648. Epub 2019 Dec 16.
5
Cardiovascular disease related death among patients with esophagus cancer: A population-based competing risk analysis.食管癌患者中心血管疾病相关死亡:一项基于人群的竞争风险分析。
Front Oncol. 2022 Sep 15;12:976711. doi: 10.3389/fonc.2022.976711. eCollection 2022.
6
Threshold dose-response association between smoking pack-years and the risk of gallbladder cancer: A nationwide cohort study.吸烟包年数与胆囊癌风险之间的阈值剂量反应关联:一项全国性队列研究。
Eur J Cancer. 2023 Feb;180:99-107. doi: 10.1016/j.ejca.2022.11.031. Epub 2022 Dec 9.
7
Second Malignant Tumors and Non-Tumor Causes of Death for Patients With Penile Cancer During Their Survivorship.阴茎癌患者生存期间的第二恶性肿瘤和非肿瘤死因。
Cancer Control. 2022 Jan-Dec;29:10732748221134789. doi: 10.1177/10732748221134789.
8
Incidence and management of gallbladder cancer in cholecystectomy specimens: a 5-year tertiary centre experience.胆囊切除术后标本中胆囊癌的发生率及处理:5 年三级中心经验。
ANZ J Surg. 2023 Oct;93(10):2481-2486. doi: 10.1111/ans.18577. Epub 2023 Jun 20.
9
Epidemiology of gallbladder cancer in the Unites States: a population-based study.美国胆囊癌的流行病学:一项基于人群的研究。
Chin Clin Oncol. 2021 Jun;10(3):25. doi: 10.21037/cco-20-230. Epub 2021 Feb 16.
10
Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016.2000 年至 2016 年美国转移性前列腺癌患者的死因。
JAMA Netw Open. 2021 Aug 2;4(8):e2119568. doi: 10.1001/jamanetworkopen.2021.19568.

引用本文的文献

1
Cardiovascular Disease and Other Competing Causes of Death in Older Kidney Cancer Patients.老年肾癌患者的心血管疾病及其他竞争性死亡原因
Rev Cardiovasc Med. 2025 Jan 14;26(1):25277. doi: 10.31083/RCM25277. eCollection 2025 Jan.
2
TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1.TRIM47是胆囊癌的一种预后生物标志物,通过调节PARP1的K63连接泛素化促进肿瘤进展。
Transl Oncol. 2025 Jan;51:102164. doi: 10.1016/j.tranon.2024.102164. Epub 2024 Nov 2.
3
Machine learning-based short-term DFS-associated characteristic factor screening and model construction for patients with gallbladder cancer after radical surgery.

本文引用的文献

1
Cardiovascular disease related death among patients with esophagus cancer: A population-based competing risk analysis.食管癌患者中心血管疾病相关死亡:一项基于人群的竞争风险分析。
Front Oncol. 2022 Sep 15;12:976711. doi: 10.3389/fonc.2022.976711. eCollection 2022.
2
A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery.基于阳性淋巴结对数优势的新型列线图预测非转移性胆囊腺癌手术后的生存情况。
Sci Rep. 2022 Oct 1;12(1):16466. doi: 10.1038/s41598-022-20933-x.
3
Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer.
基于机器学习的胆囊癌根治术后患者短期无病生存期相关特征因素筛选及模型构建
Am J Cancer Res. 2024 Sep 15;14(9):4537-4550. doi: 10.62347/XYYH1207. eCollection 2024.
4
Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights.心血管代谢综合征与胆道癌的相互作用:一项具有性别特异性见解的综合分析。
Cancers (Basel). 2024 Oct 9;16(19):3432. doi: 10.3390/cancers16193432.
5
Establishment and characterization of the gemcitabine-resistant human gallbladder cancer cell line NOZ GemR.吉西他滨耐药人胆囊癌细胞系NOZ GemR的建立与鉴定
Ann Med Surg (Lond). 2024 Jan 4;86(3):1396-1400. doi: 10.1097/MS9.0000000000001665. eCollection 2024 Mar.
原发性胆囊癌患者心血管死亡的竞争风险分析。
Cancer Med. 2023 Feb;12(3):2179-2186. doi: 10.1002/cam4.5104. Epub 2022 Aug 3.
4
Causes of death following small cell lung cancer diagnosis: a population-based analysis.小细胞肺癌诊断后的死因分析:基于人群的分析。
BMC Pulm Med. 2022 Jul 4;22(1):262. doi: 10.1186/s12890-022-02053-4.
5
Anti-PD-1-based immunotherapy plus lenvatinib to treat advanced gallbladder cancer in the elderly: a case series and review of current literature.基于抗 PD-1 的免疫疗法联合仑伐替尼治疗老年晚期胆囊癌:病例系列及文献复习。
J Cancer Res Clin Oncol. 2023 Mar;149(3):941-950. doi: 10.1007/s00432-022-04126-7. Epub 2022 Jun 27.
6
Cause of Death During Renal Cell Carcinoma Survivorship: A Contemporary, Population-Based Analysis.肾细胞癌幸存者的死亡原因:一项基于当代人群的分析。
Front Oncol. 2022 Jun 2;12:864132. doi: 10.3389/fonc.2022.864132. eCollection 2022.
7
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015.美国原发性胆囊癌发病率和基于发病率的死亡率趋势,1973 年至 2015 年。
Am J Clin Oncol. 2022 Jul 1;45(7):306-315. doi: 10.1097/COC.0000000000000918. Epub 2022 May 19.
8
Causes of Death after Prostate Cancer Diagnosis: A Population-Based Study.前列腺癌诊断后的死因:一项基于人群的研究。
Oxid Med Cell Longev. 2022 Apr 23;2022:8145173. doi: 10.1155/2022/8145173. eCollection 2022.
9
Cause of Death Among Patients With Thyroid Cancer: A Population-Based Study.甲状腺癌患者的死亡原因:一项基于人群的研究。
Front Oncol. 2022 Mar 14;12:852347. doi: 10.3389/fonc.2022.852347. eCollection 2022.
10
Infectious diseases as a cause of death among cancer patients: a trend analysis and population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results database.传染病作为癌症患者的死因:基于监测、流行病学和最终结果数据库的美国趋势分析及基于人群的结局研究。
Infect Agent Cancer. 2021 Dec 31;16(1):72. doi: 10.1186/s13027-021-00413-z.